1.
El-Beshlawy A, Youssry I. Prevention of hemoglobinopathies in Egypt.
Hemoglobin. 2009; 33 : 14
-20
2.
Vento S, Cainelli F, Cesario F. Infections and thalassaemia.
Lancet Infect Dis. 2006; 6(4) : 226
-33
[DOI][PubMed]
3.
Alavian SM. Hepatitis C infection in Iran; A review article.
Arch Clin Infect Dis. 2009; 4(1) : 47
-59
4.
Brown RJ, Gaglio PJ. Scope of worldwide hepatitis C problem.
Liver Transpl. 2003; 9(11) -3
[DOI][PubMed]
5.
Angelucci E, Pilo F. Treatment of hepatitis C in patients with thalassemia.
Haematologica. 2008; 93(8) : 1121
-3
[DOI][PubMed]
6.
Ataei B, Hashemipour M, Kassaian N, Hassannejad R, Nokhodian Z, Adibi P. Prevalence of anti HCV infection in patients with Beta-thalassemia in isfahan-iran.
Int J Prev Med. 2012; 3 -23
[PubMed]
7.
Mohammad Alizadeh AH,
Rezazadeh M,
Ranjbar M,
Fallahian F,
Hadjilooi M,
Mousavi M,
et al.
Frequencies of hepatitis B and C infections in hemophiliacs.
2006;
8.
Assarehzadegan MA, Ghafourian Boroujerdnia M, Zandian K. Prevalence of hepatitis B and C infections and HCV genotypes among haemophilia patients in ahvaz, southwest iran.
Iran Red Crescent Med J. 2012; 14(8) : 470
-4
[PubMed]
9.
Mahdaviani F, Saremi S, Rafiei M. Prevalence of hepatitis B, C and HIV infection in thalassemic and hemophilic patients of Markazi province in 2004.
2008;
10.
Prevalence of hepatitis B, C and HIV markers in thalassemic and haemophilic patients in Isfahan, Iran, 2004.
Vox Sanguinis. : 268
11.
Bozorgi SH,
Ramezani H,
Vahid T,
Mostajeri A,
Kargar FH,
Rezaei M,
et al.
The prevalence and risk factors of hepatitis C virus infection among thalassemic patients of Qazvin (2005).
2008;
12.
Kashanchi LM, Abdolrahim PH. Prevalence of HCV among thalassemia patients in Shahid Bahonar Hospital, Karaj.
2011;
13.
Najafi N, Baba M. A study on the Prevalence of chronic Hepatitis C in HCV-Ab positive patients referring to Gaemshahr Razi Hospital clinics in 1998.
2001;
14.
Boroujerdnia M, Zadegan M, Zandian K, Rodan M. Prevalence of hepatitis-C virus (HCV) among thalassemia patients in Khuzestan Province, Southwest Iran.
Pak J Med Sci Q. 2009; 25 : 113
-7
15.
Azarkar Z, Sharifzadeh G, Chahkandi T, Mahmoudi Rad A, Sandoughi M, Rezaiee N. Survey of HBV and HCV markers in haemodialysis and thalassemia, South Khorasan, Birjand 2007.
Sci J Iran Blood Transfus Organ. 2009; 6(3) : 233
-7
16.
Ansar MM, Kooloobandi A. Prevalence of hepatitis C virus infection in thalassemia and haemodialysis patients in north Iran-Rasht.
J Viral Hepat. 2002; 9(5) : 390
-2
[PubMed]
17.
Mishra D, Pensi T. Transfusion associated hepatitis C in multi-transfused thalassemic children.
Indian Pediatr. 2004; 41(3) : 287
-8
[PubMed]
18.
Marwaha RK,
Bansal D,
Sharma S,
Kumar S,
Trehan A,
Duseja A,
et al.
Seroprevalence of hepatitis C and B virus in multiply transfused beta-thalassemics: results from a thalassemic day care unit in north India.
Vox Sang. 2003; 85(2) : 119
-20
[PubMed]
19.
Jafroodi M, Davoudi-Kiakalayeh A, Mohtasham-Amiri Z, Pourfathollah AA, Haghbin A. Trend in Prevalence of Hepatitis C Virus Infection among beta-thalassemia Major Patients: 10 Years of Experience in Iran.
Int J Prev Med. 2015; 6 : 89
[DOI][PubMed]
20.
Valizadeh N, Noroozi M, Hejazi S, Nateghi S, Hashemi A. Seroprevalence of Hepatitis B, Hepatitis C and Human Immunodeficiency Viruses among Thalassemia Patients in West North of Iran.
Iran J Ped Hematol Oncol. 2015; 5(3) : 145
-8
[PubMed]
21.
Esmaeili MR, Mostafazadeh A, Sharbatdarn M, Hajiahmadi M, Alijanpoor M. Hepatitis C in blood products receivers.
Iranian J Pediat. 2004; 14(1) : 15
-20
LEAVE A COMMENT HERE: